Regulators accuse the telehealth company of sharing sensitive health information with advertising platforms including Meta ...

“Hims & Hers is mass marketing unapproved knock-off versions of Wegovy and Ozempic that evade the FDA’s gold standard review process,” said John F. Kuckelman, Novo Nordisk’s group general counsel.

NEW YORK, Feb 19 (Reuters) - Online telehealth company Hims & Hers Health, seeking growth drivers as its ⁠original ⁠sexual-health franchises matured, may have overstepped with a risky launch ⁠of ...

Hims & Hers reversed course on its launch of a cheaper, copycat version of Novo Nordisk’s GLP-1 weight loss pill amid legal action. In a Feb. 7 social media post, the San Francisco-based telehealth ...

COPENHAGEN, Feb 9 (Reuters) - Novo Nordisk sued Hims and Hers Health on ‌Monday over patent infringement after the U.S. telehealth firm launched, ‌then cancelled, a $49 copy of Novo's weight-loss pill ...

Hims & Hers says it will stop selling a low-cost copy of a new weight-loss pill made by Novo Nordisk, after federal officials raised concerns that the product may violate drug laws. The online health ...

Hims & Hers Health Inc. HIMS has decided to cease offering its compounded semaglutide pill. Hims & Hers' decision to stop offering the $49 version of Novo Nordisk A/S' NVO Wegovy comes days after the ...

Two days after offering compounded versions of oral Wegovy, telehealth company Hims & Hers pulled the product from its platform amid pressure from HHS and Novo Nordisk. On Feb. 5, Hims & Hers began ...

The ongoing feud between Novo Nordisk, makers of Ozempic and Wegovy, and Hims & Hers Health Inc. has reached a breaking point. On Monday, the pharmaceutical company announced it was filing a lawsuit ...

NEW YORK, Feb 19 (Reuters) - Online telehealth company Hims & Hers Health (HIMS.N), opens new tab, seeking growth drivers as its original sexual-health franchises matured, may have overstepped with a ...